ÂÜÀòÂÒÂ×

Alina Tudor has over 15 years of work experience in the pharmaceutical industry. Currently, they are working at Kyowa Kirin International plc. in the role of Global Head, Medical Evaluation and ICSR Review as well as Deputy Head of Medical Safety since July 2023. Prior to this, they served as a Senior Director of Pharmacovigilance at the same company starting from April 2020. Before joining Kyowa Kirin International plc., Alina worked at Norgine as an Associate Director, Senior PV Physician/Deputy EU QPPV from April 2017 to April 2020. Alina also gained experience as an EU QPPV at Voisin Consulting Life Sciences from November 2014 to April 2017 and as an EUQPPV/Pharmacovigilance Manager at Alvogen from April 2010 to October 2014. Alina's earlier positions include Drug Safety Group Leader Safety Evaluation Team at Actavis from November 2006 to April 2010 and Medical Representative at Romastru Traiding in 2006.

Alina Tudor holds a Bachelor of Science (BSc) degree in Medicine from Carol Davila Medicine and Pharmacy University in Bucharest, which was obtained from 2000 to 2006. Prior to this, they attended CN IL Caragiale in Ploiesti from 1996 to 2000, although no degree or field of study is specified. Alina also attended Liceul Pedagogic Ploiesti, but no further information is given about their studies there. Additionally, they completed the EudraVigilance User Training Course offered by the European Medicines Agency sometime before 2010.